This scenario is also consistent to what is occurring in liver specimens from human NASH in which NLRP3 positivity was detectable at immunohistochemistry in parenchymal cells and in CD68 positive macrophages (Fig 2F). Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.